Billionaire Profile
Habil Khorakiwala
Global Rank
#2805

Image: Public domain | via Wikimedia Commons

Habil Khorakiwala

CEO, Wockhardt Limited
IN
Real-Time Net Worth
$1.2B
As of December 2025
Age
83
Source
pharmaceuticals
Industry
healthcare
Citizenship
IN

Biography

Habil Khorakiwala, born in 1942, is an Indian pharmaceutical entrepreneur and the founder and chairman of Wockhardt Ltd. With an estimated net worth of $1.2 billion, Khorakiwala's wealth stems from his decades-long involvement in the pharmaceuticals industry. His career began in 1967 when he founded Wockhardt, transforming it into a leading global healthcare enterprise. Known for his vision, he steered Wockhardt through significant challenges, including a near-bankruptcy, and focused on research and development, particularly in antibiotics. Khorakiwala's achievements include pioneering innovations and leadership roles in industry organizations. He holds a Master's degree from Purdue University and has been awarded an honorary doctorate.

Wealth Over Time

In-Depth Profile

Early Life

Habil Khorakiwala was born in Bombay (now Mumbai), India, in 1942, into a prominent Dawoodi Bohra family. His father, Fakhruddin T. Khorakiwala, founded Akbarallys, India's first chain of departmental stores. Khorakiwala's early life was rooted in a strong entrepreneurial environment, setting the stage for his future endeavors.

Rise to Success

After graduating with a degree in pharmacy from L.M. College in Ahmedabad and completing a Master's degree in Pharmaceutical Sciences from Purdue University, Khorakiwala took over his father's Worli Chemical Works in 1967. He renamed it Wockhardt, marking the beginning of his independent venture. Under his leadership, Wockhardt grew from a small firm into a global pharmaceutical and biotechnology company.

Key Business Strategies

Khorakiwala focused on strategic acquisitions, expanding Wockhardt's footprint in Europe and the United States. A key strategy was investing in research and development, particularly in antibiotics, to combat antimicrobial resistance. The company launched several innovative products, including India's first pain management combination drug (PROXYVON) and recombinant hepatitis B vaccine (BIOVAC-B).

Philanthropy

Khorakiwala established the Wockhardt Foundation, which runs numerous medical and social programs. The foundation's initiatives include mobile healthcare vans providing free consultations and medicines, impacting millions of lives. He supports the integration of artificial intelligence in drug discovery to accelerate the development of treatments.

Career Milestones

1967

Founded Wockhardt

Established Wockhardt Limited, transforming a small firm into a leading pharmaceutical company.

1995

Expansion into Biotechnology

Expanded into biotechnology, producing recombinant human insulin.

2010

Honorary Doctorate

Awarded an honorary Doctor of Pharmacy degree from Purdue University.

2014

Chancellor

Appointed Chancellor of Jamia Hamdard University.

Philanthropy & Social Impact

Healthcare

Wockhardt Foundation

Undisclosed

Operates mobile healthcare vans providing free consultations and medicines.

Business Philosophy & Leadership

Notable Quotes

""Being different and making a difference.""

""The only way towards fast growth is to be 'Customer Focussed'.""

Leadership Principles

Customer Focus

Emphasizing customer needs in every decision and action.

Change Management

Single-mindedly steered Wockhardt in becoming the first true healthcare group from India

Controversies & Challenges

2021

Pandora Papers

Habil Khorakiwala and family held shares worth $20 million in a Panama firm.